On PMPRB reform, political leadership

A letter sent to the Prime Minister of Canada, co-signed by Jason Field, President & CEO of Life Sciences Ontario, Frank Béraud, President & CEO of Montréal InVivo and Mel Wong, President & CEO of BioAlberta.

Response-to-PMO-Apr-17-19 - 0,61 MB

Documents

We suggest

Overview of Venture Capital Funding for LSHT Companies in Quebec

Please note that our mapping is updated monthly. The last update was on September 30, 2025. For any suggestions for changes, please write to agouronnec@montreal-invivo.com

Vue sur les essais cliniques et les maladies rares avec le Dr Jacques Michaud

Les maladies rares demeurent largement méconnues et n’ont que peu d’options de traitement. Toutefois, la génomique, qui permet d’étudier l’ensemble du matériel gén�...

Other documents

On PMPRB reform, political leadership and evidence-based approach needed

Documents

We suggest

Studies and analysis

Overview of Venture Capital Funding for LSHT Companies in Quebec

Other documents

Vue sur les essais cliniques et les maladies rares avec le Dr Jacques Michaud

Sommaire exécutif du Plan stratégique sur les maladies rares

Other documents

On PMPRB reform, political leadership and evidence-based approach needed

Documents

We suggest

Studies and analysis

Overview of Venture Capital Funding for LSHT Companies in Quebec

Other documents

Vue sur les essais cliniques et les maladies rares avec le Dr Jacques Michaud

Sommaire exécutif du Plan stratégique sur les maladies rares

Subscribe to our newsletters

Stay informed of the industry’s breaking news by subscribing to our different type of newsletters